Fundraising FoxClovis Oncology
5 known investors
Find your way into Clovis Oncology
Sign up to see every warm intro you have to Clovis Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Clovis Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Developed targeted cancer therapies with companion diagnostics (Rubraca); IPO'd in 2011 (NASDAQ: CLVS).
Founders & leadership
Investors · 5
Aisling Capitallisted by Aisling CapitalNew York
How we know: Aisling Capital's portfolio page · Not right? Tell us
Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto
How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
New Enterprise Associates (NEA)listed by New Enterprise Associates (NEA)Menlo Park · $200K – $40M
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
Frequently asked questions
- What does Clovis Oncology do?
- Developed targeted cancer therapies with companion diagnostics (Rubraca); IPO'd in 2011 (NASDAQ: CLVS).
- Who founded Clovis Oncology?
- Clovis Oncology was founded by Patrick Mahaffy.
- Who are Clovis Oncology's investors?
- Clovis Oncology's investors include Aisling Capital, Frazier Life Sciences, New Enterprise Associates (NEA), Pfizer Venture Investments, Ridgeback Capital.